Blood Glucose Control Strategy for Type 2 Diabetes Patients With COVID-19

Since December 2019, coronavirus disease 2019 (COVID-19) caused by a novel coronavirus has spread all over the world affecting tens of millions of people. Another pandemic affecting the modern world, type 2 diabetes mellitus is among the major risk factors for mortality from COVID-19. Current eviden...

Descripción completa

Detalles Bibliográficos
Autores principales: Futatsugi, Hiroyuki, Iwabu, Masato, Okada-Iwabu, Miki, Okamoto, Koh, Amano, Yosuke, Morizaki, Yutaka, Kadowaki, Takashi, Yamauchi, Toshimasa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7655538/
https://www.ncbi.nlm.nih.gov/pubmed/33195481
http://dx.doi.org/10.3389/fcvm.2020.593061
_version_ 1783608220703522816
author Futatsugi, Hiroyuki
Iwabu, Masato
Okada-Iwabu, Miki
Okamoto, Koh
Amano, Yosuke
Morizaki, Yutaka
Kadowaki, Takashi
Yamauchi, Toshimasa
author_facet Futatsugi, Hiroyuki
Iwabu, Masato
Okada-Iwabu, Miki
Okamoto, Koh
Amano, Yosuke
Morizaki, Yutaka
Kadowaki, Takashi
Yamauchi, Toshimasa
author_sort Futatsugi, Hiroyuki
collection PubMed
description Since December 2019, coronavirus disease 2019 (COVID-19) caused by a novel coronavirus has spread all over the world affecting tens of millions of people. Another pandemic affecting the modern world, type 2 diabetes mellitus is among the major risk factors for mortality from COVID-19. Current evidence, while limited, suggests that proper blood glucose control may help prevent exacerbation of COVID-19 even in patients with type 2 diabetes mellitus. Under current circumstances where the magic bullet for the disease remains unavailable, it appears that the role of blood glucose control cannot be stressed too much. In this review the profile of each anti-diabetic agent is discussed in relation to COVID-19.
format Online
Article
Text
id pubmed-7655538
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-76555382020-11-13 Blood Glucose Control Strategy for Type 2 Diabetes Patients With COVID-19 Futatsugi, Hiroyuki Iwabu, Masato Okada-Iwabu, Miki Okamoto, Koh Amano, Yosuke Morizaki, Yutaka Kadowaki, Takashi Yamauchi, Toshimasa Front Cardiovasc Med Cardiovascular Medicine Since December 2019, coronavirus disease 2019 (COVID-19) caused by a novel coronavirus has spread all over the world affecting tens of millions of people. Another pandemic affecting the modern world, type 2 diabetes mellitus is among the major risk factors for mortality from COVID-19. Current evidence, while limited, suggests that proper blood glucose control may help prevent exacerbation of COVID-19 even in patients with type 2 diabetes mellitus. Under current circumstances where the magic bullet for the disease remains unavailable, it appears that the role of blood glucose control cannot be stressed too much. In this review the profile of each anti-diabetic agent is discussed in relation to COVID-19. Frontiers Media S.A. 2020-10-28 /pmc/articles/PMC7655538/ /pubmed/33195481 http://dx.doi.org/10.3389/fcvm.2020.593061 Text en Copyright © 2020 Futatsugi, Iwabu, Okada-Iwabu, Okamoto, Amano, Morizaki, Kadowaki and Yamauchi. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cardiovascular Medicine
Futatsugi, Hiroyuki
Iwabu, Masato
Okada-Iwabu, Miki
Okamoto, Koh
Amano, Yosuke
Morizaki, Yutaka
Kadowaki, Takashi
Yamauchi, Toshimasa
Blood Glucose Control Strategy for Type 2 Diabetes Patients With COVID-19
title Blood Glucose Control Strategy for Type 2 Diabetes Patients With COVID-19
title_full Blood Glucose Control Strategy for Type 2 Diabetes Patients With COVID-19
title_fullStr Blood Glucose Control Strategy for Type 2 Diabetes Patients With COVID-19
title_full_unstemmed Blood Glucose Control Strategy for Type 2 Diabetes Patients With COVID-19
title_short Blood Glucose Control Strategy for Type 2 Diabetes Patients With COVID-19
title_sort blood glucose control strategy for type 2 diabetes patients with covid-19
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7655538/
https://www.ncbi.nlm.nih.gov/pubmed/33195481
http://dx.doi.org/10.3389/fcvm.2020.593061
work_keys_str_mv AT futatsugihiroyuki bloodglucosecontrolstrategyfortype2diabetespatientswithcovid19
AT iwabumasato bloodglucosecontrolstrategyfortype2diabetespatientswithcovid19
AT okadaiwabumiki bloodglucosecontrolstrategyfortype2diabetespatientswithcovid19
AT okamotokoh bloodglucosecontrolstrategyfortype2diabetespatientswithcovid19
AT amanoyosuke bloodglucosecontrolstrategyfortype2diabetespatientswithcovid19
AT morizakiyutaka bloodglucosecontrolstrategyfortype2diabetespatientswithcovid19
AT kadowakitakashi bloodglucosecontrolstrategyfortype2diabetespatientswithcovid19
AT yamauchitoshimasa bloodglucosecontrolstrategyfortype2diabetespatientswithcovid19

Ejemplares similares